Taiji Matsusaka Selected Research

Taiji Matsusaka Research Topics

Disease

12	Proteinuria 01/2018 - 04/2005
9	Fibrosis (Cirrhosis) 01/2021 - 12/2002
6	Sclerosis 01/2017 - 04/2005
4	Inflammation (Inflammations) 01/2021 - 01/2017
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2016
4	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019 - 06/2005
4	Starvation 01/2019 - 01/2016
4	Kidney Diseases (Kidney Disease) 01/2018 - 07/2012
3	Reperfusion Injury 01/2022 - 01/2019
3	Hypoxia (Hypoxemia) 01/2022 - 12/2017
2	Body Weight (Weight, Body) 10/2020 - 05/2014
2	Chronic Renal Insufficiency 01/2020 - 04/2014
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 01/2017
2	Edema (Dropsy) 01/2019 - 04/2005
2	Hypertension (High Blood Pressure) 01/2017 - 01/2016
2	Ureteral Obstruction 04/2015 - 03/2011
2	Hyperplasia 01/2014 - 05/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Ischemia 10/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020
1	Hyperphosphatemia 01/2020

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2005
5	Immunotoxins (Immunotoxin)IBA 01/2019 - 04/2005
5	Angiotensin IIIBA 01/2016 - 07/2012
4	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2021 - 11/2008
4	Adenosine Triphosphate (ATP)IBA 01/2021 - 10/2017
4	AngiotensinogenIBA 01/2016 - 07/2012
3	Messenger RNA (mRNA)IBA 01/2022 - 03/2015
3	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 11/2013
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021 - 01/2016
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 10/2017
3	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2019
3	nephrinIBA 01/2016 - 04/2010
2	AngiotensinsIBA 01/2022 - 01/2002
2	Bovine Serum AlbuminIBA 01/2021 - 10/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 10/2020
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 10/2020
2	Periodic AcidIBA 01/2021 - 10/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 10/2020
2	Green Fluorescent ProteinsIBA 01/2021 - 01/2016
2	Ribosomal Protein S6IBA 01/2021 - 10/2020
2	Oleic Acid (Oleate)IBA 01/2021 - 10/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2020
2	CollagenIBA 01/2021 - 04/2005
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2021 - 10/2020
2	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 01/2021 - 10/2020
2	Lysosomal-Associated Membrane Protein 1IBA 01/2021 - 10/2020
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 10/2020
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2020
2	TOR Serine-Threonine KinasesIBA 01/2019 - 11/2013
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2017
2	AlbuminsIBA 01/2017 - 11/2013
2	5-bromo-4-chloro-3-indolyl beta-galactoside (X-gal)IBA 01/2014 - 05/2009
2	Type 1 Angiotensin ReceptorIBA 04/2010 - 12/2002
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	peroxisome-proliferator-activated receptor-gamma coactivator-1IBA 01/2021
1	pimonidazoleIBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2021
1	Eicosapentaenoic AcidIBA 01/2021
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2021
1	Diacylglycerol O-AcyltransferaseIBA 01/2021
1	alpha 1 Chain Collagen Type IIBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	oxalylglycineIBA 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	PPAR gammaIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 10/2020
1	paraform (paraformaldehyde)IBA 10/2020
1	oil red OIBA 10/2020
1	bafilomycin A1IBA 10/2020
1	enhanced green fluorescent proteinIBA 10/2020
1	AndrogensIBA 10/2020
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 10/2020
1	Carrier Proteins (Binding Protein)IBA 10/2020
1	Cathepsin DIBA 10/2020
1	ElementsIBA 10/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Hematoxylin (Haematoxylon)IBA 10/2020
1	Insulin (Novolin)FDA Link 10/2020
1	NitrogenIBA 10/2020
1	Peptide Initiation Factors (Initiation Factor)IBA 10/2020
1	SterolsIBA 10/2020
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 10/2020
1	Urea (Carbamide)FDA LinkGeneric 10/2020
1	Chloramphenicol O-Acetyltransferase (Chloramphenicol Acetyltransferase)IBA 10/2020
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 10/2020
1	Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)IBA 10/2020
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 10/2020
1	PPAR alphaIBA 10/2020
1	Class III Phosphatidylinositol 3-KinasesIBA 10/2020
1	ErbB Receptors (EGF Receptor)IBA 10/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	SodiumIBA 01/2019
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2018
1	Diphtheria ToxinIBA 12/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2017

Therapy/Procedure

1	Nephrectomy 01/2020